From 23rd June 2025, the NHS will be able to prescribe tirzepatide (Mounjaro®) to certain cohorts of patients that meet strict eligibility criteria.
Over the next 3 years, 220,000 patients in England will be eligible however initially only a very small group of patients will meet the criteria. If you don’t meet the new NHS rules, you won’t be able to get tirzepatide (Mounjaro®) through the NHS.
The roll out will be phased over the next few years. The initial group of patients is very small. At present the practice has around only 8 patients who may be eligible for the first phase of the rollout.
Patients will need to have a BMI of > 40 (adjusted for ethnicity) AND 4 out of 5 weight related long term conditions – type 2 diabetes, high blood pressure, heart and vascular disease, high cholesterol and obstructive sleep apnoea
This service has not yet been developed by the Norfolk & Waveney ICB and we are currently unable to initiate prescribing for Mounjaro to patients for Obesity until this has been agreed and developed.
The ICB is planning to commission a new dedicated support service for this and we are awaiting information on what this will be. Until we have a referral pathway the practice WILL NOT be prescribing this for weight loss.
You can get more information here – Tirzepatide (Mounjaro®) – Weight loss drug – information for patients – Norfolk & Waveney Integrated Care System (ICS
Please DO NOT call the surgery to request an appointment to discuss weight loss injections with a GP or nurse.
There are a number of local weight management services currently available for people living with obesity or overweight, and we are happy to discuss these and support you with your weight management goals.
There are a number of other programmes locally to help with weight loss – Take a look at Norfolk Country Council’s website for further support –